Next Article in Journal
Cross-Dataset Evaluation of Deep Learning Networks for Uterine Cervix Segmentation
Next Article in Special Issue
Mucinous Cancer of the Ovary: Overview and Current Status
Previous Article in Journal
Development of a Flow-Free Automated Colorimetric Detection Assay Integrated with Smartphone for Zika NS1
Previous Article in Special Issue
Sarcopenic Factors May Have No Impact on Outcomes in Ovarian Cancer Patients
Open AccessReview

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

1
Division of Gynecologic Oncology, University of Kentucky, Lexington, KY 40502, USA
2
Division of Surgical Oncology, University of Kentucky, Lexington, KY 40502, USA
*
Author to whom correspondence should be addressed.
Diagnostics 2020, 10(1), 43; https://doi.org/10.3390/diagnostics10010043
Received: 19 December 2019 / Revised: 9 January 2020 / Accepted: 10 January 2020 / Published: 14 January 2020
(This article belongs to the Special Issue Ovarian Cancer: Characteristics, Screening, Diagnosis and Treatment)
Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual tumor. HIPEC increases concentrations of chemotherapy directly within the peritoneal cavity compared with the intravenous route and reduces the systemic side effects associated with prolonged adjuvant intraperitoneal exposure. Furthermore, hyperthermia increases tissue penetration and is synergistic with the therapeutic chemotherapy agents used. In ovarian cancer, evidence is building for its use in both primary and recurrent scenarios. In this review, we examine the history of HIPEC, the techniques used, and the available data guiding its use in primary and recurrent ovarian cancer. View Full-Text
Keywords: HIPEC; ovarian cancer; peritoneal cancer; review; technique HIPEC; ovarian cancer; peritoneal cancer; review; technique
Show Figures

Figure 1

MDPI and ACS Style

Riggs, M.J.; Pandalai, P.K.; Kim, J.; Dietrich, C.S. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. Diagnostics 2020, 10, 43.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop